Genetically modified humanized minipigs could be used in therapeutic antibody testing

Medicines based on large complicated molecules adapted for the human immune system have been difficult to test in animals before heading to clinic – now one company has bred a ”humanized minipig” for the job.

The swine breed Göttingen Minipig is one-eighth the size of a regular pig, making them easier to handle for preclinical studies | Photo: Ellegaard Göttingen Minipigs /PR

Before a new medicine can reach pharmacy shelves and hospitals, it must be thoroughly tested according to the requirements of medicinal authorities. First computer modeling and test tubes, then animals, and lastly humans.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs